Trials / Completed
CompletedNCT02903615
Optimising Health in Type 1 Diabetes
The Optimal Diet for Optimising Health in Type 1 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Garvan Institute of Medical Research · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Type 1 diabetes is an autoimmune condition where circulating immune cells destroy the beta-cells in the pancreas that make insulin, resulting in a degree of insulin deficiency, whereby blood glucose levels rise and diabetes develops. When there is severe insulin deficiency, life-threatening ketoacidosis can develop. Treatment is lifelong insulin replacement therapy; dietary intervention is a also cornerstone of glucose management. The Optimise Diet is a multi-pronged diet based on "best health" principles: to minimise blood glucose rises after eating, reduce the immune cells involved in destruction of the insulin-secreting beta-cells, and improve the gut microbiome and systemic inflammation. In this study, its effects will be compared to the Standard Diabetes Diet that is currently recommended in Australia and internationally.
Detailed description
The rationale for this study is to determine whether a diet based on recent scientific advances in diet-induced inflammation, will improve diabetes care in people with type 1 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Novel diet | Novel diet to optimise glucose levels and minimise systemic inflammation: altered macronutrient composition: lower carbohydrate, Mediterranean-style, prebiotic fibre focus. |
| OTHER | Standard diet | Standard diabetes diet recommendations |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2020-06-30
- Completion
- 2020-06-30
- First posted
- 2016-09-16
- Last updated
- 2022-03-22
Locations
2 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT02903615. Inclusion in this directory is not an endorsement.